News/ News/ Sales and Marketing/ Top stories Analysts tip Inventiva’s lanifibranor as NASH blockbuster Richard Staines chronic diseases, Inventiva, lanifibranor, liver, NASH 0 Comment Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became Share X Analysts tip Inventiva’s lanifibranor as NASH blockbuster https://pharmaphorum.com/news/analyst-tip-inventivas-lanifibranor-as-nash-blockbuster-after-trial-win/
chronic diseases, Inventiva, lanifibranor, liver, NASH
0 Comment
